Eagle Strategies LLC

Position in LLY — ELI LILLY & Co

CIK 1907666 NEW YORK, NY

Position in LLY

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$5,122,765

+$1,320,436 QoQ

Shares Held

4,271

+3.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

2.55%

of 13F equity value

Holder Rank

#1,691

of 4,605 holders

Holding Since

Dec 2021

18 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Eagle Strategies LLC holds $8,022,452 across 6 Drug Manufacturers - General names. LLY ranks #1 (63.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	4,271	$5,122,765
2	JNJ	Johnson & Johnson	3,678	$934,101
3	ABBV	AbbVie Inc.	3,262	$820,849
4	NVS	Novartis AG	2,616	$409,979
5	GILD	Gilead Sciences, Inc.	3,232	$408,330
6	PFE	Pfizer Inc	13,556	$326,428

18 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,122,765	4,271	+3.3%	Shares	Sole	2026-07-21
2026-03-31	$3,802,329	4,134	+1.0%	Shares	Sole	2026-04-20
2025-12-31	$4,400,815	4,095	+3.9%	Shares	Sole	2026-01-23
2025-09-30	$3,007,746	3,942	+264.3%	Shares	Sole	2025-10-21
2025-06-30	$843,451	1,082	+0.6%	Shares	Sole	2025-07-23
2025-03-31	$888,679	1,076	+0.4%	Shares	Sole	2025-04-23
2024-12-31	$827,584	1,072	+0.2%	Shares	Sole	2025-02-14
2024-09-30	$947,955	1,070	-0.5%	Shares	Sole	2024-10-25
2024-06-30	$973,283	1,075	-11.5%	Shares	Sole	2024-08-08
2024-03-31	$945,221	1,215	+10.7%	Shares	Sole	2024-04-23
2023-12-31	$640,046	1,098	+2.1%	Shares	Sole	2024-01-26
2023-09-30	$577,414	1,075	-1.7%	Shares	Sole	2023-11-08
2023-06-30	$513,064	1,094	+3.5%	Shares	Sole	2023-08-03
2023-03-31	$362,994	1,057	+0.3%	Shares	Sole	2023-04-24
2022-12-31	$385,595	1,054	+2.6%	Shares	Sole	2023-02-06
2022-06-30	$332,984	1,027	0.0%	Shares	Sole	2022-08-10
2022-03-31	$294,101	1,027	+0.1%	Shares	Sole	2022-05-02
2021-12-31	$283,401	1,026	—	Shares	Sole	2022-02-11
No filing history on record for this holder in this stock.